The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition.
UC San Diego Health says it is trying to increase the number of trials offered but denies a report that its designation as a comprehensive cancer center is in jeopardy.